ADAGE CAPITAL PARTNERS GP, L.L.C.
Q4 2022 13F-HR Holdings
Net value change ($000)
+1,484,798
(3.7%)
New positions
96
Sold out positions
148
Turnover %
10.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CMG | 181,976 | 1648.9% |
| XOM | 180,930 | 37.6% |
| BA | 173,483 | 225.9% |
| V | 132,344 | 59.1% |
| OXY | 115,751 | 410.2% |
| Horizon Therapeutics Public Ltd Co | 113,397 | 182.1% |
| MET | 109,498 | 230.2% |
| ARGX | 108,874 | NEW |
| SB | 106,499 | NEW |
| MRK | 102,336 | 51.3% |
Top Reduces (Value $000, Stocks/ETFs)
| TSLA | -374,976 | -53.3% |
| Biohaven Pharmaceutical Holding Co Ltd. | -348,902 | -100.0% |
| AMZN | -302,730 | -28.9% |
| AAPL | -174,394 | -8.2% |
| Change Healthcare Inc. | -165,824 | -100.0% |
| HON | -153,472 | -100.0% |
| AVALARA, INC. | -153,306 | -100.0% |
| TXT | -127,000 | -68.4% |
| BURL | -126,678 | -94.3% |
| DLTR | -118,822 | -75.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|